Back to search results

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Superficial Bladder Cancer · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The University of Alabama at Birmingham Clinical Research Unit (CRU), Birmingham, Alabama, United States

  • Mayo Clinic, Scottsdale, Arizona, United States

  • Urological Associates of South Arizona, Tucson, Arizona, United States

  • Arkansas Urology, Little Rock, Arkansas, United States

  • University of California - Irvine Medical Center, Irvine, California, United States

    Contact: Study coordinator (Edward Uchio) · euchio@uci.edu

  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Salmasi

  • USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Anne Schuckman) · anne.schuckman@med.usc.edu · 323-865-3700

  • Tower Urology, Los Angeles, California, United States

    Contact: Study coordinator (Terry Williams) · williamst@towerurology.com · 310-854-9898

  • Om Research, San Diego, California, United States

    Contact: Study coordinator (Alanna Gavriushina) · Alanna.gavriushina@uniohp.com · 858-430-1101
    Contact: Study coordinator (Katayune Golshan) · Katayune.golshan@uniohp.com

  • Colorado Clinical Research, Lakewood, Colorado, United States

  • The George Washington Medical Faculty Associates, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Michael Whalen) · mwhalen@mfa.gwu.edu · 202-741-2798

  • University of Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Kethandapatti Balaji) · kc.balaji@jax.ufl.edu · 904-244-7340

  • Sylvester Comprehensive Cancer Center / University of Miami Hospital and Clinics, Miami, Florida, United States

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Shreyas Joshi) · shreyas.joshi@emory.edu · 404-778-4898

  • Georgia Cancer Center at Augusta University, Augusta, Georgia, United States

  • Urology of Indiana, Greenwood, Indiana, United States

  • University of Kansas Medical Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Faith Rahman) · frahman2@kumc.edu · 913-588-2502
    Contact: Study coordinator (Laura Mitchell) · Lmitchell11@kumc.edu · 913-574-2854

  • John Hopkins Hospital, Baltimore, Maryland, United States

  • Chesapeake Urology Research Associates, Hanover, Maryland, United States

    Contact: Study coordinator (Rian Dickstein) · rdickstein@cua.md

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Mark Preston) · MPRESTON@BWH.HARVARD.EDU
    Contact: Study coordinator (Saachi Pawa) · bwhurologyrcs@partners.org · 617-525-8793

  • Henry Ford Health System, Detroit, Michigan, United States

    Contact: Study coordinator (Johar Raza, MD) · jraza1@hfhs.org · 716-697-0305

  • Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Conrad Tobert) · 616-267-7333

  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Marissa Twedt) · twedt050@umn.edu · 612-626-6661
    Contact: Study coordinator (Joseph Zabell) · zabe0034@umn.edu

  • Mayo Clinic, Rochester, Minnesota, United States

    Shah

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Packiam

  • New Jersey Urology, LLC, Voorhees Township, New Jersey, United States

    Contact: Study coordinator (Gordon Brown) · gbrown@njurology.com

  • Albany Medical College, Albany, New York, United States

  • Roswell Park Cancer Institute, Buffalo, New York, United States

  • Mount Sinai Medical Center, New Haven, New York, United States

    Contact: Study coordinator (John Sfakianos) · john.sfakianos@mountsinai.or

  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States

  • Associated Medical Professionals of NY,, Syracuse, New York, United States

  • UNC Chapel Hill Hospital, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Marc Bjurlin) · marc_bjurlin@med.unc.edu · 919-966-8217

  • Duke Health - Duke Cancer Center, Durham, North Carolina, United States

  • Associated Urologists of North Carolina, Raleigh, North Carolina, United States

    Contact: Study coordinator (Mark Jalkut) · mjalkut@gmail.com · 919-782-1255

  • University of Cincinnati Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Mohammed Kamel) · kamelme@ucmail.uc.edu · 513-558-0983

  • Central Ohio Urology Group, Gahanna, Ohio, United States

  • Clinical Research Solutions - Helios Clinical Research, Middleburg Heights, Ohio, United States

    Contact: Study coordinator (Kara Lasorella) · kara.lasorella@heliosclinical.com · 440-340-9010

  • Oregon Health & Science University (OHSU), Portland, Oregon, United States

    Contact: Study coordinator (J Liu) · jenj@ohsu.edu · 610-659-7113

  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States

  • Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina, United States

    Contact: Study coordinator (Neal Shore) · nshore@auclinics.com · 843-449-1010

  • Urology Associates, P.C., Nashville, Tennessee, United States

    Jayram

  • Vanderbilt Univerity Medical Center, Nashville, Tennessee, United States

    Chang

  • Urology Austin, Austin, Texas, United States

  • UT Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Jose Santoyo) · jose.santoyo@utsouthwestern.edu · 214-645-8764
    Contact: Study coordinator (Yair Lotan) · Yair.Lotan@UTSouthwestern.edu

  • Houston Metro Urology, Houston, Texas, United States

    Gelpi-Hammerschmidt

  • Houston Methodist Hospital - Department of Urology, Houston, Texas, United States

    Contact: Study coordinator (Taliah Muhammad) · tnmuhammad@houstonmethodist.org · 346-238-4523

  • University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Ashish Kamat, MD) · akamat@mdanderson.org · 713-792-3250

  • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States

  • University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Christine Ibilibor) · ci5d@uvahealth.org

  • Froedtert Hospital / Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Scott Johnson) · scjohnson@mcw.edu · 414-955-0867

  • Sydney Adventist Hospital, Wahroonga, New South Wales, Australia

  • Gold Coast University Hospital, Southport, Queensland, Australia

  • Icon Cancer Center Windsor Gardens, Windsor Gardens, South Australia, Australia

  • Prostate Cancer Centre, Calgary, Alberta, Canada

  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada

  • Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

    Contact: Study coordinator (Ricardo Rendon) · Ricardo.Rendon@nshealth.ca
    Contact: Study coordinator (Robin Simpson) · robin.simpson@nshealth.ca

  • University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  • McGill University Health Center - Glen site, Montreal, Quebec, Canada

    Contact: Study coordinator (W Kassouf) · wassim.kassouf@mcgill.ca · 514-934-1934
    Contact: Study coordinator (K Jaureguisanchez) · Karla.Jaureguisanchez@muhc.mcgill.ca · 514-934-1934

  • CHUM Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada

  • CHU d'Angers, Angers, France

  • CHU Bordeaux Pellegrin, Bordeaux, France

  • lnstitut Bergonie 229 Cour de l'Argonne, Bordeaux, France

  • CHU de Lille, Lille, France

  • Hospices Civils de Lyon, Lyon, France

  • Hopital Bichat Claude-Bernard, Paris, France

  • CHU de Rauen- Hopital Charles Nicolle, Rouen, France

  • Klinik fur Urologie, Uro-Onkologie, spezielle urologische und Roboter-assistierte Chirurgie Universitatsklinikum Koln (AOR), Cologne, Germany

  • Urologicum Duisburg, Duisburg, Germany

  • Universitaetsklinikum Erlangen, Erlangen, Germany

  • Urologie Neandertal Mettmann, Mettmann, Germany

  • Studienpraxis Urologie, Nürtingen, Germany

  • Universitaetsklinikum Tubingen, Tübingen, Germany

  • Clinic Unit of Urology, IRCCS Ospedale San Raffaele, Milan, MI, Italy

  • Istituto Europeo di Oncologia, Milan, Italy

  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy

  • Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Largo, Rome, Italy

  • Azienda Ospedaliero-Universitaria Sant'Andrea, Rome, Italy

  • UOC Urologia, IFO- lstituto Tumori "Regina Elena", Rome, Italy

  • Ospedelae Molinette San Giovanni Battista Di Torino, Torino, Italy

  • Seoul National University Bundang Hospital, Seongnam, Gyunggi-do, South Korea

  • Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • The Catholic University of Korea, Soul St. Mary's Hospital, Seoul, South Korea

  • IOB - Hospital Quironsalud Barcelona, Barbera Del Valles, Spain

  • Fundacio Puigvert, Barcelona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain

  • Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Quironsalud Madrid (Next Oncology), Madrid, Spain

  • Hospital Universitario Infanta Sofia, Madrid, Spain

  • Hospital General Universitario Morales Meseguer, Murcia, Spain

  • Hospital Universitario Marqués de Valdecilla,, Santander, Spain

  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan

  • China Medical University Hospital, Taichung, Taiwan

  • Taichung Veterans General Hospital, Taichung, Taiwan

  • Chi Mei Medical Center, Tainan, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • The Royal Marsden NHS Foundation Trust, London, United Kingdom

Study leads

  • Christine Tosone, Ms, RAC

    Study Director

    enGene, Inc.

View source on ClinicalTrials.gov(opens in a new tab)